deoxycytidine kinase (dCK) and thymidine kinases (tetrameric high-affinity form of TK1, and TK2) from human leukemic spleen. In particular, the analogues included the mono- and di-O'-methyl derivatives of dC, dU and dA, syntheses of which are described. In general, purine nucleosides with modified sugar rings were feebler substrates than the corresponding cytosine analogues. Sugar-modified analogues of dU were
已经检查了具有修饰的糖部分的核苷类似物对人类白血病脾脏的高度纯化的脱氧
胞苷激酶(dCK)和
胸苷激酶(TK1和TK2的四聚体高亲和力形式)的底物/
抑制剂特异性。特别地,类似物包括dC,dU和dA的单-和二-O'-甲基衍
生物,描述了它们的合成。通常,具有修饰的糖环的
嘌呤核苷比相应的
胞嘧啶类似物更弱。糖修饰的dU类似物也是TK1和TK2的底物相对较弱,但还是相当好的
抑制剂,与TK2相比,Ki值通常低于TK1。TK1和TK2之间的出色区分是3'-己酰
氨基-2',3'-二脱氧
胸苷,TK1的Ki约为600 microM,Ki约为0。TK2为1 microM。3'-OMe-dC是dCK优于其5'-O-甲基同类物的
抑制剂,与作为质子受体的(3')-OH或(3')-OMe的氧可能参与氢键结合与酶。令人惊讶的是,alpha-dT是TK1和TK2的良好底物,TK1和TK2的Ki值分别为120和30 microM